ALX Oncology Holdings Inc (ALXO)
1.27
-0.02
(-1.55%)
USD |
NASDAQ |
Nov 18, 09:35
ALX Oncology Holdings Price: 1.27 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 1.35 | 1.35 | 1.25 | 1.29 | 573880.0 |
| Nov 14, 2024 | 1.33 | 1.38 | 1.325 | 1.33 | 1.387M |
| Nov 13, 2024 | 1.35 | 1.41 | 1.295 | 1.34 | 1.022M |
| Nov 12, 2024 | 1.47 | 1.50 | 1.34 | 1.34 | 983869.0 |
| Nov 11, 2024 | 1.50 | 1.575 | 1.47 | 1.48 | 738507.0 |
| Nov 08, 2024 | 1.55 | 1.63 | 1.44 | 1.45 | 917803.0 |
| Nov 07, 2024 | 1.53 | 1.555 | 1.450 | 1.51 | 808133.0 |
| Nov 06, 2024 | 1.54 | 1.57 | 1.44 | 1.53 | 739318.0 |
| Nov 05, 2024 | 1.48 | 1.52 | 1.446 | 1.52 | 498216.0 |
| Nov 04, 2024 | 1.45 | 1.565 | 1.43 | 1.49 | 791145.0 |
| Nov 01, 2024 | 1.41 | 1.515 | 1.40 | 1.45 | 752799.0 |
| Oct 31, 2024 | 1.39 | 1.47 | 1.335 | 1.43 | 1.094M |
| Oct 30, 2024 | 1.42 | 1.44 | 1.36 | 1.38 | 1.045M |
| Oct 29, 2024 | 1.46 | 1.53 | 1.37 | 1.40 | 979585.0 |
| Oct 28, 2024 | 1.47 | 1.525 | 1.43 | 1.46 | 792921.0 |
| Oct 25, 2024 | 1.50 | 1.505 | 1.46 | 1.47 | 298689.0 |
| Oct 24, 2024 | 1.67 | 1.67 | 1.45 | 1.455 | 823799.0 |
| Oct 23, 2024 | 1.48 | 1.770 | 1.46 | 1.66 | 1.285M |
| Oct 22, 2024 | 1.47 | 1.57 | 1.46 | 1.50 | 1.857M |
| Oct 21, 2024 | 1.48 | 1.555 | 1.43 | 1.50 | 637384.0 |
| Oct 18, 2024 | 1.50 | 1.51 | 1.45 | 1.48 | 327637.0 |
| Oct 17, 2024 | 1.56 | 1.57 | 1.48 | 1.51 | 752080.0 |
| Oct 16, 2024 | 1.56 | 1.62 | 1.55 | 1.56 | 588682.0 |
| Oct 15, 2024 | 1.56 | 1.575 | 1.52 | 1.56 | 385920.0 |
| Oct 14, 2024 | 1.55 | 1.61 | 1.50 | 1.55 | 316989.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.27
Minimum
Nov 18 2024
112.26
Maximum
Dec 10 2020
26.03
Average
13.25
Median
Aug 26 2022
Price Benchmarks
| Biomarin Pharmaceutical Inc | 63.35 |
| Neurocrine Biosciences Inc | 117.80 |
| Eton Pharmaceuticals Inc | 10.30 |
| Verve Therapeutics Inc | 4.80 |
| Immuneering Corp | 1.79 |
Price Related Metrics
| PS Ratio | 17.71 |
| Price to Book Value | 0.4896 |
| Earnings Yield | -233.9% |
| Market Cap | 66.98M |